STOCK OPTIONS AND WARRANTS (Details 4) |
9 Months Ended |
|---|---|
|
Sep. 30, 2022
$ / shares
shares
| |
| Exercisable, Number of Options | 848,559 |
| Warrants Exercisable [Member] | |
| Weighted average remaining life in years | 2 years 7 months 6 days |
| Exercisable, Number of Options | 333,855 |
| Exercise price | $ / shares | $ 5.06 |
| Warrants Exercisable [Member] | 5.06 [Member] | |
| Weighted average remaining life in years | 2 years 7 months 6 days |
| Exercisable, Number of Options | 333,855 |
| Exercise price | $ / shares | $ 5.06 |
| Warrants Outstanding [Member] | |
| Weighted average remaining life in years | 2 years 7 months 6 days |
| Exercise price | $ / shares | $ 5.06 |
| Number of outstanding | 333,855 |
| Warrants Outstanding [Member] | 5.06 [Member] | |
| Weighted average remaining life in years | 2 years 7 months 6 days |
| Exercise price | $ / shares | $ 5.06 |
| Number of outstanding | 333,855 |
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|